Phibro Animal Health Corp To Close Chicago Heights Facility In Summer 2027, Affecting About 100 Employees

Phibro Animal Health Corporation Class A

Phibro Animal Health Corporation Class A

PAHC

0.00

MFA SITE CLOSURE

Through the MFA acquisition in 2024, Phibro added several manufacturing facilities. Since then, we have conducted a comprehensive review of our manufacturing network to ensure our production footprint is aligned with current business needs and future operational requirements. As a result, we have decided to close our Chicago Heights manufacturing facility as part of a strategic consolidation of our manufacturing network. Production at the site is expected to cease during the summer of 2027. Approximately 100 employees will be affected. Manufacturing of products currently produced at Chicago Heights will be transferred to other Phibro-owned facilities and select third-party contract manufacturers.